2024-07-22T14:01:49-04:00 2023-12-31 261631527 BURGE & ASSOCIATES PC 315 W PONCE DE LEON AVE STE 700 DECATUR GA 30030 990 2023-01-01 582445245 THE OVARIAN CANCER INSTITUTE INC OVAR 4046660317 1266 W PACES FERRY ROAD SUITE 339 ATLANTA GA 30327 DANA WHITLOW CHAIRPERSON 4043002997 2024-07-22 true DANA WHITLOW XXX-XX-XXXX false LUCAS M BRADSTREET P01580932 7704466649 2024-07-22 2023 2023-04-26 12:10:37Z DANA WHITLOW 1266 W PACES FERRY ROAD SUITE 339 ATLANTA GA 30327 986021 false X WWW.OVARIANCANCERINSTITUTE.ORG X 1999 GA THE OVARIAN CANCER INSTITUTE DEVELOPS INNOVATIVE RESEARCH FOR EARLY DETECTION AND MORE EFFECTIVE TREATMENT OF CANCER, PROVIDES EDUCATIONAL OPPORTUNITIES FOR MEDICAL PROFESSIONALS, EDUCATES AND HEIGHTENS AWARENESS OF OVARIAN CANCER SYMPTOMS AND THEIR TREATMENT OPTIONS. 14 13 2 30 0 576742 980159 0 16 5762 95517 -87348 672275 898573 682508 365000 0 169067 199260 0 93895 61452 84700 913027 648960 -240752 249613 351433 602015 3800 4770 347633 597245 X THE OVARIAN CANCER INSTITUTE EXISTS TO (1) DEVELOP INNOVATIVE RESEARCH LEADING TO EARLIER DETECTION AND MORE EFFECTIVE CONTROL OF OVARIAN CANCER (2) TO EDUCATE AND HEIGHTEN WOMEN'S AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND TREATMENT (3) TO INVESTIGATE NEWER MODALITIES OF TREATMENT. false false 517633 365000 THE OVARIAN CANCER INSTITUTE CONTINUES SUPPORTING OVARIAN CANCER RESEARCH PROJECTS THAT HAVE SUCCESSFULLY DEVELOPED A BLOOD TEST FOR OVARIAN CANCER THAT HAS NO FALSE POSITIVES (NECESSARY FOR A DISEASE WITH A 1/78 PREVALENCE IN THE POPULATION), AND WHICH IDENTIFIES 98% OF EARLY-STAGE OVARIAN CANCERS AND 89% OF LATE-STAGE OVARIAN CANCERS. THIS TEST WILL SOON BE SUBMITTED FOR FDA APPROVAL. FURTHERMORE, WE HAVE CREATED AI TOOLS THAT CAN OFTEN SUCCESSFULLY PREDICT WHAT DRUGS ARE LIKELY TO BE EFFECTIVE IN A GIVEN PATIENT WITH OVARIAN CANCER, AND ARE DEVELOPING A QUANTITATIVE UNDERSTANDING OF THE NEUROLOGICAL EFFECTS OF ANTICANCER DRUGS. FINALLY, WE ARE DEVELOPING TOOLS THAT CAN IDENTIFY CIRCULATING OVARIAN CANCER TUMOR CELLS, BEFORE THE METASTASES ARE DETECTABLE BY STANDARD APPROACHES. 517633 true true false false false false false false false false false false false false false false true false false false false false false false true false false true false false false false false false false false false false false false false false false false false false false true 6 0 true 2 true false false false false false false false false X 14 13 false false false false false false false true true false false false true true true false false true true false X KRISTIN KRANCER 4046660317 1266W PACES FERRY ROAD SUITE 339 ATLANTA GA 30327 KRISTIN KRANCER EXECUTIVE DI 40.00 X 97467 0 0 DANA WHITLOW CHAIRPERSON 10.00 X 0 0 0 VICKI BARNETT COO 10.00 X 0 0 0 BECCA KRUMDIECK TREASURER 10.00 X 0 0 0 MARCI KNAUSS SECRETARY 1.00 X 0 0 0 KIM CHAMPNEY BOARD MEMBER 1.00 X 0 0 0 DELORES RAPOPORT BOARD MEMBER 1.00 X 0 0 0 ELIZABETH COOPER BOARD MEMBER 1.00 X 0 0 0 NANCY RAMPELL BOARD MEMBER 1.00 X 0 0 0 MARIA SAPORTA BOARD MEMBER 1.00 X 0 0 0 CHARLES SHERON BOARD MEMBER 1.00 X 0 0 0 CHIARA VISCONTI BOARD MEMBER 1.00 X 0 0 0 HILLYER YOUNG BOARD MEMBER 1.00 X 0 0 0 RICHARD ZANE BOARD MEMBER 1.00 X 0 0 0 CYRIL SPANN JR BOARD MEMBER 1.00 X 0 0 0 97467 false false false 287549 692610 980159 5762 5762 287549 87448 -87448 OTHER REVENUE 100 100 100 898573 5862 365000 365000 97468 58092 5068 34308 92462 55109 4807 32546 2000 1192 104 704 7330 4369 381 2580 1079 643 56 380 7826 4664 407 2755 4055 2417 211 1427 13284 7917 691 4676 8239 4911 428 2900 562 335 29 198 5762 3434 300 2028 PROFESSIONAL FEES 17028 13278 3750 BANK & MERCHANT FEES 10837 10837 SUPPLIES 9554 5694 497 3363 OTHER EXPENSES 3778 2250 197 1331 2696 1606 141 949 648960 517633 37432 93895 182570 602015 168863 351433 602015 3800 4770 3800 4770 X 347633 547245 50000 347633 597245 351433 602015 X 249613 -1 X false true X true X 762290 721924 639321 576742 980159 3680436 762290 721924 639321 576742 980159 3680436 3680436 420 16 5762 6198 247 236 483 3687117 431554 0.99820 0.99950 X PART II, LINE 10 483 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 986021 87448 87448 898573 898573 736408 87448 87448 648960 648960 SCHEDULE D, PAGE 4, PART XI, LINE 2D EVENT INCOME 87,448 SCHEDULE D, PAGE 4, PART XII, LINE 2D EVENT EXPENSES 87,448 EVENING OF HONO 161457 161457 34320 TEAL CUP GOLF 120442 120442 53021 1 5650 5650 107 287549 287549 87448 87448 -87448 true GEORGIA TECH FOUNDATION INC 760 SPRING STREET NW STE 400 ATLANTA GA 30308 586043294 365000 BOOK OVARIAN CANCER RESEA FORM 990 - ORGANIZATION'S MISSION THE OVARIAN CANCER INSTITUTE EXISTS TO (1) DEVELOP INNOVATIVE RESEARCH LEADING TO EARLIER DETECTION AND MORE EFFECTIVE CONTROL OF OVARIAN CANCER (2) TO EDUCATE AND HEIGHTEN WOMEN'S AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND TREATMENT (3) TO INVESTIGATE NEWER MODALITIES OF TREATMENT. FORM 990, PAGE 6, PART VI, LINE 11B THE FORM 990 IS REVIEWED BY THE TREASURER AND THE FINANCE COMMITTEE BEFORE IT IS FILED. FORM 990, PAGE 6, PART VI, LINE 12C BOARD MEMBERS ARE REQUIRED TO SIGN AN ANNUAL STATEMENT THAT THEY HAVE READ AND ARE AWARE OF THE POLICY, AND ARE TO REPORT ANY POTENTIAL CONFLICTS OF INTEREST TO THE BOARD AS THEY ARISE. WHEN A POTENTIAL CONFLICT IS DISCLOSED, THE INDIVIDUAL SHALL TAKE NO FURTHER PART IN THE MEETING DURING WHICH TIME THE PROPOSAL IS CONSIDERED VOTED UPON. FORM 990, PAGE 6, PART VI, LINE 15A INDEPENDENT OFFICERS & BOARD REVIEW EXECUTIVE WAGES FOR REASONABLENESS PRIOR TO DISCUSSION AND DELIBERATION. FORM 990, PAGE 6, PART VI, LINE 15B INDEPENDENT OFFICERS & BOARD REVIEW EXECUTIVE WAGES FOR REASONABLENESS PRIOR TO DISCUSSION AND DELIBERATION. FORM 990, PAGE 6, PART VI, LINE 19 NO OTHER DOCUMENTS AVAILABLE TO THE PUBLIC.